CareRx Performance
| CHHHFDelisted Stock | USD 1.70 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0428, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CareRx's returns are expected to increase less than the market. However, during the bear market, the loss of holding CareRx is expected to be smaller as well. CareRx right now shows a risk of 0.0%. Please confirm CareRx information ratio, skewness, as well as the relationship between the Skewness and day median price , to decide if CareRx will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days CareRx has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, CareRx is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 19.6 M | |
| Total Cashflows From Investing Activities | -93.2 M |
CareRx |
CareRx Relative Risk vs. Return Landscape
If you would invest 170.00 in CareRx on January 19, 2024 and sell it today you would earn a total of 0.00 from holding CareRx or generate 0.0% return on investment over 90 days. CareRx is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than CareRx, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
CareRx Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CareRx's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as CareRx, and traders can use it to determine the average amount a CareRx's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CHHHF |
Based on monthly moving average CareRx is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CareRx by adding CareRx to a well-diversified portfolio.
CareRx Fundamentals Growth
CareRx Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CareRx, and CareRx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CareRx Pink Sheet performance.
| Return On Equity | -0.49 | |||
| Return On Asset | 0.0204 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 170.84 M | |||
| Shares Outstanding | 51.96 M | |||
| Price To Earning | 13.57 X | |||
| Price To Book | 1.78 X | |||
| Price To Sales | 0.22 X | |||
| Revenue | 262.63 M | |||
| EBITDA | 6.15 M | |||
| Cash And Equivalents | 15.2 M | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 106.11 M | |||
| Debt To Equity | 2.35 % | |||
| Book Value Per Share | 1.24 X | |||
| Cash Flow From Operations | 7.27 M | |||
| Earnings Per Share | (0.38) X | |||
| Total Asset | 282.82 M | |||
About CareRx Performance
To evaluate CareRx Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when CareRx generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare CareRx Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand CareRx market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents CareRx's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.CareRx Corporation, together with its subsidiaries, provides specialty pharmacy services to seniors in Canada. CareRx Corporation was incorporated in 2001 and is headquartered in Toronto, Canada. Carerx Corp operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 1378 people.Things to note about CareRx performance evaluation
Checking the ongoing alerts about CareRx for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CareRx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CareRx is not yet fully synchronised with the market data | |
| CareRx may become a speculative penny stock | |
| CareRx has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 262.63 M. Net Loss for the year was (22.73 M) with profit before overhead, payroll, taxes, and interest of 75.28 M. | |
| About 30.0% of the company shares are held by company insiders |
- Analyzing CareRx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CareRx's stock is overvalued or undervalued compared to its peers.
- Examining CareRx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CareRx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CareRx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CareRx's pink sheet. These opinions can provide insight into CareRx's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the CareRx information on this page should be used as a complementary analysis to other CareRx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in CareRx Pink Sheet
If you are still planning to invest in CareRx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CareRx's history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |